Record overview
Status and phase
Status: UNKNOWN
Phase: PHASE1, PHASE2
Sponsor: Istituto Nazionale Tumori IRCCS - Fondazione G. Pascale
Condition: Recurrent Adult Hodgkin Lymphoma
NCT01412307
A Phase 1/2 Study of Lenalidomide in Combination With Bendamustine in Relapsed and Primary Refractory Hodgkin Lymphoma
Public trial-level signal summary for this oncology Phase 2 record.
Signal summary
Public flags
Status signal: Unknown Status Signal
Timeline signals: stale_update_signal | primary_completion_date_past_signal | completion_date_past_signal
Results signal: Low Signal
Operational burden: None
Stopped reason
Context when available
No stop reason available in the current public record.